ProfileGDS4718 / 214095_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 74% 52% 59% 60% 53% 83% 80% 64% 51% 65% 61% 58% 83% 83% 91% 73% 63% 84% 93% 64% 63% 68% 67% 64% 71% 81% 56% 84% 60% 83% 83% 79% 49% 56% 80% 83% 83% 58% 57% 61% 65% 81% 75% 75% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.1992174
GSM549102patient 115, normal, homogenized [OPG study]5.6777652
GSM549104patient 119, normal, homogenized [OPG study]6.076259
GSM549108patient 138, normal, homogenized [OPG study]6.1489460
GSM549119patient 077, normal, homogenized [OPG study]5.7197453
GSM549133patient 032, cancer, homogenized [OPG study]8.4004183
GSM549139patient 042, cancer, homogenized [OPG study]7.8870880
GSM549099patient 107, normal, homogenized [OPG study]6.3718164
GSM549109patient 139, normal, homogenized [OPG study]5.6002851
GSM549110patient 046, normal, homogenized [OPG study]6.4794865
GSM549114patient 063, normal, homogenized [OPG study]6.1778661
GSM549122patient 082, normal, homogenized [OPG study]6.008358
GSM549134patient 033, cancer, homogenized [OPG study]8.2002783
GSM549136patient 036, cancer, homogenized [OPG study]8.3175683
GSM549140patient 044, cancer, homogenized [OPG study]9.4686891
GSM549111patient 047, normal, homogenized [OPG study]7.2097573
GSM549113patient 057, normal, homogenized [OPG study]6.3468863
GSM549132patient 031, cancer, homogenized [OPG study]8.3006284
GSM549137patient 038, cancer, homogenized [OPG study]9.7180393
GSM549142patient 047, cancer, homogenized [OPG study]6.4509664
GSM549100patient 110, normal, homogenized [OPG study]6.3209563
GSM549107patient 135, normal, homogenized [OPG study]6.6648568
GSM549115patient 068, normal, homogenized [OPG study]6.6091967
GSM549116patient 072, normal, homogenized [OPG study]6.4056664
GSM549120patient 078, normal, homogenized [OPG study]6.9632471
GSM549131patient 030, cancer, homogenized [OPG study]8.0570781
GSM549118patient 074, normal, homogenized [OPG study]5.8941656
GSM549129patient 027, cancer, homogenized [OPG study]8.2866184
GSM549123patient 088, normal, homogenized [OPG study]6.1642760
GSM549124patient 006, cancer, homogenized [OPG study]8.1038383
GSM549126patient 015, cancer, homogenized [OPG study]8.1973983
GSM549128patient 025, cancer, homogenized [OPG study]7.8818279
GSM549103patient 117, normal, homogenized [OPG study]5.5011849
GSM549117patient 073, normal, homogenized [OPG study]5.8403156
GSM549138patient 041, cancer, homogenized [OPG study]7.9403380
GSM549141patient 045, cancer, homogenized [OPG study]8.3092183
GSM549130patient 028, cancer, homogenized [OPG study]8.1537183
GSM549101patient 111, normal, homogenized [OPG study]6.0268158
GSM549105patient 128, normal, homogenized [OPG study]5.9558957
GSM549106patient 134, normal, homogenized [OPG study]6.1716961
GSM549112patient 048, normal, homogenized [OPG study]6.482465
GSM549125patient 011, cancer, homogenized [OPG study]7.9241981
GSM549127patient 024, cancer, homogenized [OPG study]7.4630975
GSM549135patient 035, cancer, homogenized [OPG study]7.4290475